Impact Of Personalized Medicine On The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Continues To Impact The Growth Of The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Growth In Market Size Of The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market During 2026–2030?
The market size for in vitro diagnostic (IVD) products in cardiology and neurology has experienced robust growth in recent years. Forecasts indicate an expansion from $17.22 billion in 2025 to $18.71 billion by 2026, achieving a compound annual growth rate (CAGR) of 8.7%. This historical expansion can be linked to several factors, including the increasing prevalence of cardiovascular conditions, a rise in neurological disorder cases, the development of hospital diagnostic facilities, innovations in immunoassay techniques, and heightened clinical understanding of the importance of early diagnosis.
The in vitro diagnostic (ivd) in cardiology and neurology market size is anticipated to experience robust expansion over the next few years. It is projected to reach $25.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast period is driven by factors such as an aging global demographic, increasing demand for personalized diagnostics, the proliferation of point-of-care testing facilities, rising healthcare expenditure within emerging markets, and the wider adoption of molecular diagnostics. Prominent trends expected in this period include an escalating demand for early disease detection, the growing acceptance of point-of-care cardiac and neuro tests, the broadening of biomarker-based diagnostics, a heightened focus on preventive and predictive testing, and the integration of multi-parameter diagnostic panels.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15829&type=smp
Which Strategic Drivers Are Supporting The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Development?
The projected increase in personalized medicine is anticipated to stimulate the expansion of the in vitro diagnostic (IVD) in cardiology and neurology market. Personalized medicine describes a medical strategy where healthcare choices, methods, interventions, and therapies are customized based on each patient’s unique attributes. This approach is gaining traction due to progress in genomics, enhanced comprehension of disease mechanisms, patient desire for customized treatments, and regulatory backing, among other elements. In vitro diagnostic (IVD) tests in cardiology and neurology are instrumental in advancing personalized medicine by offering vital data concerning an individual’s genetic profile and disease state, thereby informing customized treatment strategies for better effectiveness and reduced dangers. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit research organization, reported that the U.S. Food and Drug Administration sanctioned 16 novel personalized treatments for rare disease patients in 2023, marking an increase from six approvals in 2022, with the 2023 approvals additionally covering seven oncology therapies and three treatments aimed at various other ailments. Consequently, the rising adoption of personalized medicines is propelling the growth of the in vitro diagnostic (IVD) in cardiology and neurology market.
How Is The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Structured Across Different Market Segments?
The in vitro diagnostic (ivd) in cardiology and neurology market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Technology: Immunoassays, Molecular Diagnostics, Hematology, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Other End-Users
Subsegments:
1) By Instruments: Diagnostic Analyzers, Point-Of-Care Devices
2) By Reagents And Consumables: Diagnostic Reagents, Test Kits, Assay Consumables
3) By Software And Services: Diagnostic Software, Data Management Software, IVD Consulting And Support Services
Which Trends Are Expected To Shape The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
Leading companies operating within the in vitro diagnostic (IVD) market for cardiology and neurology are actively developing AI-enabled integrated epigenetic engines aimed at early disease detection and risk assessment. These AI-powered integrated epigenetic engines harness machine-learning models and sophisticated biomarker analysis techniques to elevate the sensitivity and accuracy in diagnosing and monitoring cardiovascular diseases, thereby addressing significant factors driving disease progression. For instance, in February 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology firm, launched PrecisionCHD, an AI-based blood test designed for the early identification of coronary heart disease (CHD). Utilizing the company’s integrated epigenetic-genetic engine, this test assesses CHD risk and seeks to prevent and detect the most prevalent form of cardiovascular disease. The innovative test integrates epigenetic and genetic biomarkers with machine-learning algorithms, providing over 75% sensitivity for both men and women. It connects a patient’s biomarker profile to modifiable risk factors that are major contributors to CHD, such as smoking, diabetes, hypertension, and high cholesterol. PrecisionCHD offers a non-invasive alternative to exercise stress tests or angiograms, with blood samples capable of being drawn in-office or at home.
Which Companies Are Engaged In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Environment?
Major companies operating in the in vitro diagnostic (ivd) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMérieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience
Access The Complete In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Report:
What Is The Largest Regional Market In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (ivd) in cardiology and neurology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=15829&type=smp
Browse Through More Reports Similar to the Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market 2026, By The Business Research Company
In Vitro Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
In Vitro Diagnostics Ivd Quality Control Global Market Report 2026
Bioinformatics In In Vitro Diagnostics Ivd Testing Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
